PE20010996A1 - Uso de compuestos de 4-amino-1-fenilbutano-2-ol sustituidos como reguladores para el sistema nociceptina/orfanina fq ligando de receptor orl1 y para la preparacion de medicamentos - Google Patents

Uso de compuestos de 4-amino-1-fenilbutano-2-ol sustituidos como reguladores para el sistema nociceptina/orfanina fq ligando de receptor orl1 y para la preparacion de medicamentos

Info

Publication number
PE20010996A1
PE20010996A1 PE2000001400A PE0014002000A PE20010996A1 PE 20010996 A1 PE20010996 A1 PE 20010996A1 PE 2000001400 A PE2000001400 A PE 2000001400A PE 0014002000 A PE0014002000 A PE 0014002000A PE 20010996 A1 PE20010996 A1 PE 20010996A1
Authority
PE
Peru
Prior art keywords
orphanine
phenylbutane
amino
ligando
nociceptin
Prior art date
Application number
PE2000001400A
Other languages
English (en)
Inventor
Stephan Wnendt
Werner Englberger
Bernd Sundermann
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20010996A1 publication Critical patent/PE20010996A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

SE REFIERE AL USO DE 4-AMINO-1-FENILBUTANO-2-OL SUSTITUIDO DE FORMULA I, DONDE A ES ARILO, HETEROARILO; R1 Y R2 SON ALQUILO C1-C6, O JUNTOS FORMAN (CH2)(2-6); R3 Y R4 SON ALQUILO C1-C6, ARILO O JUNTOS FORMAN (CH2)(3-6), CH2CH2OCH2CH2; R5, R6, R7 SON H, F, Cl, Br, I, CF3, OR8, SO2CH3, SO2CF3, FENILO, CN, ENTRE OTROS; R8 ES H, ALQUILO C1-C6, ARILO, HETEROARILO. SON COMPUESTOS PREFERIDOS 1-(2-CLOROBENCIL)-2-(DIMETILAMINOFENILMETIL)CICLOHEXANOL, 1-(3-CLOROBENCIL)-2-(DIMETILAMINOFENILMETIL)CICLOHEXANOL, ENTRE OTROS. EL COMPUESTO ACTUA SOBRE EL SISTEMA NOCICEPTINA/ORFANINA FQ LIGANDO DE RECEPTOR ORL1 Y PUEDE SER UTIL PARA EL TRATAMIENTO DE ANSIEDAD, DEPRESION, DIURESIS, HIPOTENSION, HIPERTENSION, DEMENCIA SENIL, ALZHEIMER, DISFUNCIONES CONGENITAS GENERALES, TINITUS, SORDERA, EPILEPSIA, OBESIDAD, CAQUEXIA
PE2000001400A 1999-12-27 2000-12-26 Uso de compuestos de 4-amino-1-fenilbutano-2-ol sustituidos como reguladores para el sistema nociceptina/orfanina fq ligando de receptor orl1 y para la preparacion de medicamentos PE20010996A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19963175A DE19963175A1 (de) 1999-12-27 1999-12-27 Verwendung von substituierten 4-Amino-1-phenylbutan-2-ol-Verbindungen als Arzneimittel

Publications (1)

Publication Number Publication Date
PE20010996A1 true PE20010996A1 (es) 2001-10-06

Family

ID=7934620

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001400A PE20010996A1 (es) 1999-12-27 2000-12-26 Uso de compuestos de 4-amino-1-fenilbutano-2-ol sustituidos como reguladores para el sistema nociceptina/orfanina fq ligando de receptor orl1 y para la preparacion de medicamentos

Country Status (17)

Country Link
US (1) US7012099B2 (es)
EP (1) EP1253917B1 (es)
JP (1) JP2003518491A (es)
AR (1) AR032294A1 (es)
AT (1) ATE289195T1 (es)
AU (1) AU776229B2 (es)
CA (1) CA2396516A1 (es)
CO (1) CO5251442A1 (es)
DE (2) DE19963175A1 (es)
ES (1) ES2236018T3 (es)
HU (1) HUP0203900A3 (es)
MX (1) MXPA02006398A (es)
NZ (1) NZ519933A (es)
PE (1) PE20010996A1 (es)
PT (1) PT1253917E (es)
UY (1) UY26508A1 (es)
WO (1) WO2001047506A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030320A1 (es) 2001-07-17 2003-04-03 Gruenenthal Chemie Derivados sustituidos de 4-aminociclohexanol
DE10135636A1 (de) * 2001-07-17 2003-02-06 Gruenenthal Gmbh Substituierte 4-Aminocyclohexanole
DE10161809A1 (de) 2001-12-14 2003-06-26 Gruenenthal Gmbh Arzneimittel enthaltend N,N'-disubstituierte Piperazin-Verbindungen
DE10161818A1 (de) * 2001-12-14 2003-06-26 Gruenenthal Gmbh Substituierte 1,5-Diaminopentan-3-ol-Verbindungen
DE102004023507A1 (de) 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexylessigsäure-Derivate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913279A1 (en) * 1990-09-26 1992-04-08 Astra Ab (2-Thienyl)alkylamine Derivatives Having Neuroprotective¹Properties
FR2776016B1 (fr) 1998-03-12 2000-06-30 Lucas Conwell Frederic Perfectionnement d'un moteur a combustion interne a injection
RU2202344C2 (ru) * 1998-03-26 2003-04-20 Джапан Тобакко Инк. Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции
DE19915601A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
WO2001047506A2 (de) 2001-07-05
JP2003518491A (ja) 2003-06-10
AU776229B2 (en) 2004-09-02
CA2396516A1 (en) 2001-07-05
UY26508A1 (es) 2001-01-31
DE19963175A1 (de) 2001-07-12
MXPA02006398A (es) 2003-04-10
HUP0203900A3 (en) 2005-06-28
DE50009567D1 (de) 2005-03-24
US20030008859A1 (en) 2003-01-09
NZ519933A (en) 2003-08-29
AU2168801A (en) 2001-07-09
HUP0203900A2 (hu) 2003-07-28
EP1253917A2 (de) 2002-11-06
ES2236018T3 (es) 2005-07-16
ATE289195T1 (de) 2005-03-15
AR032294A1 (es) 2003-11-05
PT1253917E (pt) 2005-05-31
CO5251442A1 (es) 2003-02-28
WO2001047506A3 (de) 2002-01-24
US7012099B2 (en) 2006-03-14
EP1253917B1 (de) 2005-02-16

Similar Documents

Publication Publication Date Title
CA2247443A1 (en) Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
RS50537B (sr) Derivati benzimidazola i njihovo korišćenje kao antagonista receptora a ii
UY25873A1 (es) Derivados de 3-azabiciclo [3.1.0] hexano útiles en terapia en afecciones mediadas por receptores opiáceos
ATE293101T1 (de) Piperidine zur verwendung als orexin rezeptor antagonisten
IT1231413B (it) Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
ATE63553T1 (de) Chinazolindione und pyridopyrimidindione.
PE2799A1 (es) Lactamas e imidas heterociclicas de aralquilo y aralquilideno
ATE542805T1 (de) Ppar-delta aktivatoren
DE69613240T2 (de) N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden
WO2003011028A1 (en) Substituted amides and pest controllers
PE20010522A1 (es) Aminoalcoxicarbazoles como antagonistas de los receptores 5ht
AR035111A1 (es) Procedimiento para preparar un compuesto de pirimidinona
PE20010996A1 (es) Uso de compuestos de 4-amino-1-fenilbutano-2-ol sustituidos como reguladores para el sistema nociceptina/orfanina fq ligando de receptor orl1 y para la preparacion de medicamentos
DE602004002579D1 (de) Herstellung und verwendung von 2-substituierten 5-oxo-3-pyrazolidincarboxylaten
PT1442006E (pt) Preparacao de anfetaminas a partir de fenilpropanolaminas
PE20060584A1 (es) Derivados de piridina como antagonistas de receptores de cannabinoides cb1 y procedimiento de preparacion
AR051936A1 (es) Proceso para la preparacion de pirazoles
PE20020413A1 (es) Derivados de 1-aminobutano-3-ol como agonistas de la gabapentina
AR013183A1 (es) Procedimiento para producir un compuesto derivado de indol, compuestos obtenidos e intermediarios
WO1999023092A3 (en) 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
CO4810299A1 (es) Procedimiento para alquilar sulfonamidas impedidas esteri- camente
ES444437A1 (es) Un procedimiento para preparar fenilalquilaminas.
PT89064A (pt) Processo para a preparacao de compostos piperidinil-1,4-dissubstituidos com accao analgesica e miorrelaxante
RS49832B (sr) Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijanje jedinjenja i upotreba ovih jedinjenja
ATE314348T1 (de) 1-acyl-7-nitroindolin derivate, deren herstellung und deren verwendung als photospaltbare vorstufen

Legal Events

Date Code Title Description
FA Abandonment or withdrawal